{"id":"oxysonium","rwe":[],"tags":[{"label":"oxysonium","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"hydroxythiospasmin","offLabel":[],"synonyms":["oxysonium","hydroxythiospasmin","oxysonium iodide"],"timeline":[],"approvals":[],"brandName":"Hydroxythiospasmin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"oxysonium","explanation":"Imagine your body's cells have locks on them, and oxysonium is a key that fits into one of those locks. When it binds, it triggers a series of events that ultimately lead to a desired outcome, such as reducing inflammation or blocking a harmful process.","oneSentence":"Oxysonium works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Oxysonium is a small molecule that binds to a specific protein or receptor, altering its function and leading to a downstream effect on cellular processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2040","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXYSONIUM","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:12:00.723062","biosimilars":[],"competitors":[],"genericName":"oxysonium","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"878BVP1Q4D","CHEBI":"CHEBI:135380","INN_ID":"1788","UMLSCUI":"C2981298","ChEMBL_ID":"CHEMBL2111015","PUBCHEM_CID":"71524","SECONDARY_CAS_RN":"24869-49-6"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hydroxythiospasmin, also known as Oxysonium, is a small molecule oxysonium drug with an unknown target. Its exact mechanism of action and approved indications are not well-documented. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand this compound. Its development and current ownership are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}